Additionally, while the MOLT-3 T-ALL control line was responsive to combination therapy, the p53 knockout MOLT-3 line did not demonstrate a response with a ZIP synergy score of −1.48 ± 2.61 (Fig. S2E, F), suggesting the synergic effect of therapy is p53-dependent. Here, TP53 is linked to acute lymphoblastic leukemia.